Lloydspharmacy warns that clinical senates need bite
The government hadto ensure that commissioners listened to senate views while curtailing additional bureaucracy, Lloydspharmacy said in a discussion paper on NHS plans revealed last week.
"One promising option would be to place a duty on local clinical commissioning groups to consult [senates] when patient pathways are redesigned," Lloydspharmacy proposed. A national clinical senate should also be established to advise the NHS commissioning board.
Only one senate should be tied to each commissioning group to ensure it becomes the "natural focus of advice for commissioners", the Lloydspharmacy paper added.
Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments.
